170 related articles for article (PubMed ID: 31962054)
1. Device profile of different paclitaxel-coated balloons: Neuro Elutax SV, Elutax '3' Neuro and SeQuent Please NEO for the treatment of symptomatic intracranial high-grade stenosis: overview of their feasibility and safety.
Gruber P; Remonda L
Expert Rev Med Devices; 2020 Feb; 17(2):87-92. PubMed ID: 31962054
[No Abstract] [Full Text] [Related]
2. Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study.
Gruber P; Braun C; Kahles T; Hlavica M; Anon J; Diepers M; Nedeltchev K; Berberat J; Remonda L
J Neurointerv Surg; 2019 Jul; 11(7):719-722. PubMed ID: 30415229
[TBL] [Abstract][Full Text] [Related]
3. Angioplasty Using Drug-Coated Balloons in Ostial Vertebral Artery Stenosis.
Gruber P; Berberat J; Kahles T; Anon J; Diepers M; Nedeltchev K; Remonda L
Ann Vasc Surg; 2020 Apr; 64():157-162. PubMed ID: 31639484
[TBL] [Abstract][Full Text] [Related]
4. Neuro Elutax SV drug-eluting balloon versus Wingspan stent system in symptomatic intracranial high-grade stenosis: a single-center experience.
Gruber P; Garcia-Esperon C; Berberat J; Kahles T; Hlavica M; Anon J; Diepers M; Nedeltchev K; Remonda L
J Neurointerv Surg; 2018 Dec; 10(12):e32. PubMed ID: 29627786
[TBL] [Abstract][Full Text] [Related]
5. Drug-Coated Balloon Treatment in Symptomatic Intracranial High Grade Stenosis : A Retrospective Study of 33 Patients.
Remonda L; Diepers M; Berberat J; Kahles T; Anon J; Nedeltchev K; Gruber P
Clin Neuroradiol; 2021 Mar; 31(1):45-49. PubMed ID: 32691077
[TBL] [Abstract][Full Text] [Related]
6. Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.
Schneider PA; Laird JR; Doros G; Gao Q; Ansel G; Brodmann M; Micari A; Shishehbor MH; Tepe G; Zeller T
J Am Coll Cardiol; 2019 May; 73(20):2550-2563. PubMed ID: 30690141
[TBL] [Abstract][Full Text] [Related]
7. Leave Nothing Behind: Treatment of Intracranial Atherosclerotic Disease with Drug-Coated Balloon Angioplasty.
Wang AY; Chang CH; Chen CC; Wu YM; Lin CM; Chen CT; Hsieh PC
Clin Neuroradiol; 2021 Mar; 31(1):35-44. PubMed ID: 32720067
[TBL] [Abstract][Full Text] [Related]
8. Drug-Coated Balloon Dilation Compared With Conventional Stenting Angioplasty for Intracranial Atherosclerotic Disease.
Zhang J; Zhang X; Zhang J; Song Y; Zheng M; Sun L; Meng Y; Zhao W; Yin H; Wang W; Han J
Neurosurgery; 2020 Oct; 87(5):992-998. PubMed ID: 32445576
[TBL] [Abstract][Full Text] [Related]
9. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
11. Application of drug-coated balloons for intracranial atherosclerosis disease: a systematic review.
Li G; Qiao H; Lin H; Wang R; Chen F; Li S; Yang W; Yin L; Cen X; Zhang Y; Cheng X; Wang AY
Clin Neurol Neurosurg; 2022 Feb; 213():107065. PubMed ID: 34991058
[TBL] [Abstract][Full Text] [Related]
12. 12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S; Willfort-Ehringer A; Sievert H; Geist V; Lichtenberg M; Del Giudice C; Sauguet A; Diaz-Cartelle J; Marx C; Ströbel A; Schult I; Scheinert D;
JACC Cardiovasc Interv; 2018 May; 11(10):934-941. PubMed ID: 29730375
[TBL] [Abstract][Full Text] [Related]
13. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B;
JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665
[TBL] [Abstract][Full Text] [Related]
15. SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the Düsseldorf DCB registry.
Assadi-Schmidt A; Mohring A; Liebsch E; Dannenberg L; Achilles A; Pöhl M; Afzal S; Veulemans V; Horn P; Sansone R; Bönner F; Levkau B; Kelm M; Zeus T; Polzin A
Int J Cardiol; 2017 Mar; 231():68-72. PubMed ID: 28089147
[TBL] [Abstract][Full Text] [Related]
16. Comparison of drug-coated balloon with conventional balloon for angioplasty in symptomatic intracranial atherosclerotic stenosis.
Tang Y; Li T; Liu W; He Y; Zhu L; Wang ZL; He Y
J Neurointerv Surg; 2023 Dec; 15(e3):e369-e374. PubMed ID: 36604174
[TBL] [Abstract][Full Text] [Related]
17. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
18. Drug-Coated Balloon Angioplasty Compared With Uncoated Balloons in the Treatment of 200 Chinese Patients With Severe Femoropopliteal Lesions: 24-Month Results of AcoArt I.
Xu Y; Jia X; Zhang J; Zhuang B; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W
JACC Cardiovasc Interv; 2018 Dec; 11(23):2347-2353. PubMed ID: 30448170
[TBL] [Abstract][Full Text] [Related]
19. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
Schneider PA; Laird JR; Tepe G; Brodmann M; Zeller T; Scheinert D; Metzger C; Micari A; Sachar R; Jaff MR; Wang H; Hasenbank MS; Krishnan P;
Circ Cardiovasc Interv; 2018 Jan; 11(1):e005891. PubMed ID: 29326153
[TBL] [Abstract][Full Text] [Related]
20. Drug-Coated Balloons for the Treatment of Symptomatic Intracranial High-Grade Stenosis: A Review of the Current Rationale.
Gruber P; Singh S; Andereggen L; Berberat J; Remonda L
Front Neurol; 2021; 12():692208. PubMed ID: 34385971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
